Combination of Niclosamide and Pirfenidone Alleviates Pulmonary Fibrosis by Inhibiting Oxidative Stress and MAPK/Nf-κB and STATs Regulated Genes

The pathogenesis of pulmonary fibrosis (PF) is extremely complex and involves numerous intersecting pathways. The successful management of PF may require combining multiple agents. There is a growing body of evidence that suggests the potential benefits of niclosamide (NCL), an FDA-approved anthelmi...

Descripción completa

Detalles Bibliográficos
Autores principales: Wanas, Hanaa, Elbadawy, Hossein M., Almikhlafi, Mohannad A., Hamoud, Amany E., Ali, Eid N., Galal, Amr M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10222172/
https://www.ncbi.nlm.nih.gov/pubmed/37242480
http://dx.doi.org/10.3390/ph16050697

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10222172/
https://www.ncbi.nlm.nih.gov/pubmed/37242480
http://dx.doi.org/10.3390/ph16050697

Ejemplares similares